Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study

Ronald Tutrone,Fred Saad,Daniel J. George,Bertrand Tombal, James L. Bailen,Michael S. Cookson,Daniel R. Saltzstein,Sarah Hanson,Bruce Brown,Sophia Lu,Mark Fallick,Neal D. Shore

European Urology Oncology（2023）

引用 0|浏览4

暂无评分

摘要

Testosterone recovery to the lower limit of normal testosterone levels was faster 90 d after discontinuation of therapy with relugolix than with leuprolide acetate. Younger men and men with a higher median baseline testosterone level had a higher likelihood of testosterone recovery.

查看译文

关键词

Advanced prostate cancer,Leuprolide,Prostate-specific antigen,Relugolix,Testosterone recovery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要